Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

This study has been completed.
Xiansheng Pharmaceutical Company
Information provided by (Responsible Party):
Shen Lin, Peking University Identifier:
First received: February 11, 2009
Last updated: May 17, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)